©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 107980
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.107980
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.107980
Table 2 Tumor responses of fibrinogen to albumin ratio < 0.08 and fibrinogen to albumin ratio ≥ 0.08, n (%)
| Variables | Low FAR (n = 123) | High FAR (n = 137) | χ2 | P value |
| CR | ||||
| 0 | 121 (98.37) | 136 (99.27) | ||
| 1 | 2 (1.63) | 1 (0.73) | ||
| PR | ||||
| 0 | 101 (82.11) | 124 (90.51) | ||
| 1 | 22 (17.89) | 13 (9.49) | ||
| SD | ||||
| 0 | 86 (69.92) | 104 (75.91) | ||
| 1 | 37 (30.08) | 33 (24.09) | ||
| PD | ||||
| 0 | 61 (49.59) | 47 (34.31) | ||
| 1 | 62 (50.41) | 90 (65.69) | ||
| ORR | 4.49 | 0.034 | ||
| 0 | 99 (80.49) | 123 (89.78) | ||
| 1 | 24 (19.51) | 14 (10.22) | ||
| DCR | 6.24 | 0.013 | ||
| 0 | 62 (50.41) | 90 (65.69) | ||
| 1 | 61 (49.59) | 47 (34.31) |
- Citation: Yao ZY, Liu J, Ma X, Li WT, Shen Y, Cui YZ, Fang Y, Han ZX, Yang CH. Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy. World J Gastrointest Oncol 2025; 17(6): 107980
- URL: https://www.wjgnet.com/1948-5204/full/v17/i6/107980.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.107980